Show simple item record

dc.contributor.authorKunter, İ.en_US
dc.contributor.authorKandemiş, E.en_US
dc.contributor.authorAlotaibi, Hanien_US
dc.contributor.authorCanda, T.en_US
dc.contributor.authorBağrıyanık, E. E.en_US
dc.date.accessioned2018-04-12T10:59:41Z
dc.date.available2018-04-12T10:59:41Z
dc.date.issued2017en_US
dc.identifier.issn1300-0152
dc.identifier.urihttp://hdl.handle.net/11693/37000
dc.description.abstractING1 has regulatory roles in the expression of genes associated with proliferation, apoptosis, and senescence. p33(ING1b) is the most widely expressed isoform of the gene. Downregulation of its nuclear expression is involved in differentiation and pathogenesis in invasive breast carcinoma. Yet the mechanism(s) by which p33 nuclear targeting is regulated remains unknown. In this study, we analyzed human invasive breast carcinoma tissue samples by immunostaining with p33 and correlating p33 location with the presence of ERα. Our findings show the expression of p33 protein in ERα-positive tumor samples was in the nucleus alone, while the expression was mainly in the cytoplasm in ERα-negative tumor samples. Examination of the localization of p33 in the nucleus and/or cytoplasm in several different cell lines demonstrated 17β-estradiol (E2) treatment causes dramatic compartmental shift in p33 protein from the cytoplasm to the nucleus in ERα-positive MDA-66 cells. No significant differences in ERα-negative MDA-MB-231 cells in the same conditions were observed. We show for the first time nuclear localization of p33 is regulated by estradiol induction in ERα-positive breast cancer cells. These results suggest compartmental shift in p33 by ER signaling may be an important molecular event in the differentiation and pathogenesis of invasive breast cancer. © TÜBİTAK.en_US
dc.language.isoEnglishen_US
dc.source.titleTurkish Journal of Biologyen_US
dc.relation.isversionofhttp://dx.doi.org/10.3906/biy-1602-95en_US
dc.subjectEstrogen receptor alphaen_US
dc.subjectInvasive breast carcinomaen_US
dc.subjectP33(ING1b)en_US
dc.titleAlteration in the subcellular location of the inhibitor of growth protein p33(ING1b) in estrogen receptor alpha positive breast carcinoma cellsen_US
dc.typeArticleen_US
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.citation.spage105en_US
dc.citation.epage112en_US
dc.citation.volumeNumber41en_US
dc.citation.issueNumber1en_US
dc.identifier.doi10.3906/biy-1602-95en_US
dc.publisherScientific and Technical Research Council of Turkeyen_US
dc.contributor.bilkentauthorAlotaibi, Hani


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record